HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status

Detalhes bibliográficos
Autor(a) principal: Richardson, Lyndsay Ann
Data de Publicação: 2015
Outros Autores: El-Zein, Mariam, Ramanakumar, Agnihotram V., Ratnam, Samuel, Sangwa-Lugoma, Ghislain, Longatto Filho, Adhemar, Cardoso, Marly Augusto, Coutlee, Francois, Franco, Eduardo L., The PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/40471
Resumo: BACKGROUND: Knowledge of cervical human papillomavirus (HPV) status might influence a cytotechnician's assessment of cellular abnormalities. The authors compared original cytotechnicians' Papanicolaou (Pap) readings for which HPV status was concealed with Pap rereads for which HPV status was revealed separately for 3 screening populations. METHODS: Previously collected cervical Pap smears and clinical data were obtained from the Canadian Cervical Cancer Screening Trial (study A), the Democratic Republic of Congo Community-Based Screening Study (study B), and the Brazilian Investigation into Nutrition and Cervical Cancer Prevention (study C). Smears were reread with knowledge of HPV status for all HPV-positive women as well as a sample of HPV-negative women. Diagnostic performance of Pap cytology was compared between original readings and rereads. RESULTS: A total of 1767 Pap tests were reread. Among 915 rereads for HPV-positive women, the contrast between "revealed" and "concealed" Pap readings demonstrated revisions from negative to positive results for 109 women (cutoff was atypical squamous cells of undetermined significance or worse) and 124 women (cutoff was low-grade squamous intraepithelial lesions [LSIL] or worse). For a disease threshold of cervical intraepithelial neoplasia of grade 2 or worse, specificity significantly declined at the atypical squamous cells of undetermined significance cutoff for studies A (86.6% to 75.3%) and C (42.5% to 15.5%), and at the LSIL cutoff for study C (61.9% to 37.6%). Sensitivity remained nearly unchanged between readings, except in study C, in which reread performance was superior (91.3% vs 71.9% for the LSIL cutoff). CONCLUSIONS: A reduction in the diagnostic accuracy of Pap cytology was observed when revealing patients' cervical HPV status, possibly due to a heightened awareness of potential abnormalities, which led to more false-positive results. Cancer (Cancer Cytopathol) 2015. (c) 2015 American Cancer Society.
id RCAP_8fc89ab7b0a6f9961f10caabb709a79d
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/40471
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection statusCervical cancerHuman papillomavirus (HPV)Papanicolaou testScreeningCiências Médicas::Medicina BásicaScience & TechnologyBACKGROUND: Knowledge of cervical human papillomavirus (HPV) status might influence a cytotechnician's assessment of cellular abnormalities. The authors compared original cytotechnicians' Papanicolaou (Pap) readings for which HPV status was concealed with Pap rereads for which HPV status was revealed separately for 3 screening populations. METHODS: Previously collected cervical Pap smears and clinical data were obtained from the Canadian Cervical Cancer Screening Trial (study A), the Democratic Republic of Congo Community-Based Screening Study (study B), and the Brazilian Investigation into Nutrition and Cervical Cancer Prevention (study C). Smears were reread with knowledge of HPV status for all HPV-positive women as well as a sample of HPV-negative women. Diagnostic performance of Pap cytology was compared between original readings and rereads. RESULTS: A total of 1767 Pap tests were reread. Among 915 rereads for HPV-positive women, the contrast between "revealed" and "concealed" Pap readings demonstrated revisions from negative to positive results for 109 women (cutoff was atypical squamous cells of undetermined significance or worse) and 124 women (cutoff was low-grade squamous intraepithelial lesions [LSIL] or worse). For a disease threshold of cervical intraepithelial neoplasia of grade 2 or worse, specificity significantly declined at the atypical squamous cells of undetermined significance cutoff for studies A (86.6% to 75.3%) and C (42.5% to 15.5%), and at the LSIL cutoff for study C (61.9% to 37.6%). Sensitivity remained nearly unchanged between readings, except in study C, in which reread performance was superior (91.3% vs 71.9% for the LSIL cutoff). CONCLUSIONS: A reduction in the diagnostic accuracy of Pap cytology was observed when revealing patients' cervical HPV status, possibly due to a heightened awareness of potential abnormalities, which led to more false-positive results. Cancer (Cancer Cytopathol) 2015. (c) 2015 American Cancer Society.Financial support for the Canadian Cervical Cancer Screening Trial was provided by the Canadian Institutes of Health Research (CIHR) (grant MCT-54063 to Dr. Franco). The Democratic Republic of Congo's Cervical Screening Study was funded by the Program for Appropriate Technology in Health (grant to Dr. Sangwa-Lugoma). The Brazilian Investigation into Nutrition and Cervical Cancer Prevention study received funding from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant to Dr. Cardoso). Additional support for the work performed in rereading Papanicolaou tests was provided by a CIHR team grant (83320 to Dr. Franco). Additional support for human papillomavirus testing and genotyping was provided by the above CIHR team grant and the Reseau FRQS SIDA-MI.WileyUniversidade do MinhoRichardson, Lyndsay AnnEl-Zein, MariamRamanakumar, Agnihotram V.Ratnam, SamuelSangwa-Lugoma, GhislainLongatto Filho, AdhemarCardoso, Marly AugustoCoutlee, FrancoisFranco, Eduardo L.The PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium2015-122015-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/40471engRichardson, L. A., El-Zein, M., Ramanakumar, A. V., Ratnam, S., Sangwa-Lugoma, G., Longatto-Filho, A., . . . S, P. P. E. C. H. (2015). HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status. Cancer Cytopathology, 123(12), 745-754.1934-662X10.1002/cncy.2159626230283http://onlinelibrary.wiley.com/doi/10.1002/cncy.21596/fullinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:03:59Zoai:repositorium.sdum.uminho.pt:1822/40471Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:54:10.267737Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
title HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
spellingShingle HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
Richardson, Lyndsay Ann
Cervical cancer
Human papillomavirus (HPV)
Papanicolaou test
Screening
Ciências Médicas::Medicina Básica
Science & Technology
title_short HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
title_full HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
title_fullStr HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
title_full_unstemmed HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
title_sort HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status
author Richardson, Lyndsay Ann
author_facet Richardson, Lyndsay Ann
El-Zein, Mariam
Ramanakumar, Agnihotram V.
Ratnam, Samuel
Sangwa-Lugoma, Ghislain
Longatto Filho, Adhemar
Cardoso, Marly Augusto
Coutlee, Francois
Franco, Eduardo L.
The PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium
author_role author
author2 El-Zein, Mariam
Ramanakumar, Agnihotram V.
Ratnam, Samuel
Sangwa-Lugoma, Ghislain
Longatto Filho, Adhemar
Cardoso, Marly Augusto
Coutlee, Francois
Franco, Eduardo L.
The PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Richardson, Lyndsay Ann
El-Zein, Mariam
Ramanakumar, Agnihotram V.
Ratnam, Samuel
Sangwa-Lugoma, Ghislain
Longatto Filho, Adhemar
Cardoso, Marly Augusto
Coutlee, Francois
Franco, Eduardo L.
The PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium
dc.subject.por.fl_str_mv Cervical cancer
Human papillomavirus (HPV)
Papanicolaou test
Screening
Ciências Médicas::Medicina Básica
Science & Technology
topic Cervical cancer
Human papillomavirus (HPV)
Papanicolaou test
Screening
Ciências Médicas::Medicina Básica
Science & Technology
description BACKGROUND: Knowledge of cervical human papillomavirus (HPV) status might influence a cytotechnician's assessment of cellular abnormalities. The authors compared original cytotechnicians' Papanicolaou (Pap) readings for which HPV status was concealed with Pap rereads for which HPV status was revealed separately for 3 screening populations. METHODS: Previously collected cervical Pap smears and clinical data were obtained from the Canadian Cervical Cancer Screening Trial (study A), the Democratic Republic of Congo Community-Based Screening Study (study B), and the Brazilian Investigation into Nutrition and Cervical Cancer Prevention (study C). Smears were reread with knowledge of HPV status for all HPV-positive women as well as a sample of HPV-negative women. Diagnostic performance of Pap cytology was compared between original readings and rereads. RESULTS: A total of 1767 Pap tests were reread. Among 915 rereads for HPV-positive women, the contrast between "revealed" and "concealed" Pap readings demonstrated revisions from negative to positive results for 109 women (cutoff was atypical squamous cells of undetermined significance or worse) and 124 women (cutoff was low-grade squamous intraepithelial lesions [LSIL] or worse). For a disease threshold of cervical intraepithelial neoplasia of grade 2 or worse, specificity significantly declined at the atypical squamous cells of undetermined significance cutoff for studies A (86.6% to 75.3%) and C (42.5% to 15.5%), and at the LSIL cutoff for study C (61.9% to 37.6%). Sensitivity remained nearly unchanged between readings, except in study C, in which reread performance was superior (91.3% vs 71.9% for the LSIL cutoff). CONCLUSIONS: A reduction in the diagnostic accuracy of Pap cytology was observed when revealing patients' cervical HPV status, possibly due to a heightened awareness of potential abnormalities, which led to more false-positive results. Cancer (Cancer Cytopathol) 2015. (c) 2015 American Cancer Society.
publishDate 2015
dc.date.none.fl_str_mv 2015-12
2015-12-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/40471
url http://hdl.handle.net/1822/40471
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Richardson, L. A., El-Zein, M., Ramanakumar, A. V., Ratnam, S., Sangwa-Lugoma, G., Longatto-Filho, A., . . . S, P. P. E. C. H. (2015). HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status. Cancer Cytopathology, 123(12), 745-754.
1934-662X
10.1002/cncy.21596
26230283
http://onlinelibrary.wiley.com/doi/10.1002/cncy.21596/full
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132323621371904